Ibex Medical Analytics

About:

IBEX is a Medical technology manufacturer that develops AI-powered diagnostic solutions to help pathologists.

Website: https://ibex-ai.com

Twitter/X: IbexMedAx

Top Investors: Octopus Ventures, Dell Technologies Capital, aMoon Fund, DigitalHealth.London Accelerator, 83North

Description:

Ibex Medical Analytics was conceived when its two founders were looking for ways to apply their skills to contribute to human well-being. They were captivated with the opportunity presented by applying artificial intelligence (AI) to medicine and, in particular, the potential it holds for advancing cancer care. They decided to combine their accumulated knowledge of AI, data science, image analysis, and machine learning, and apply it to cancer diagnostics in digital pathology. Today, Ibex is a multidisciplinary team comprised of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision: Applying AI to cancer diagnostics, striving to improve patient outcomes and quality of life.

Total Funding Amount:

$118M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tel Aviv-yafo, Tel Aviv, Israel

Founded Date:

2016-01-01

Contact Email:

info(AT)ibex-ai.com

Founders:

Chaim Linhart, Joseph Mossel

Number of Employees:

11-50

Last Funding Date:

2023-09-06

IPO Status:

Private

© 2024 MyAiNote.com